| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,452 | 0,496 | 16:52 | |
| 0,452 | 0,478 | 16:42 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ACOTEC SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| 23.09. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.09. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 31.08. | ACOTEC-B (06669): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 1 | HKEx | ||
| 19.08. | ACOTEC-B (06669): NOTICE OF BOARD MEETING | - | HKEx | ||
| 12.08. | ACOTEC-B (06669): INSIDE INFORMATION PROFIT WARNING | - | HKEx | ||
| 16.06. | ACOTEC-B (06669): AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | 2 | HKEx | ||
| 16.06. | ACOTEC-B (06669): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 16, 2026 | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RESMED | 215,40 | -0,23 % | RESMED INC: Form 8-K | ||
| CARDINAL HEALTH | 250,50 | +0,93 % | Wells Fargo raises Cardinal Health stock price target on pharma strength | ||
| ZIMMER BIOMET | 93,02 | +0,37 % | Zimmer Biomet upgraded at Wells Fargo on Monogram orthopedic robot | ||
| UNIDOC HEALTH | 0,028 | -5,96 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,130 | -20,84 % | Co-Diagnostics Announces Reverse Stock Split | SALT LAKE CITY, Nov. 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Diagnostics" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CLARIANE | 3,324 | +0,42 % | Clariane: Signing of a new €700 million syndicated revolving credit facility maturing 2031 | 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September... ► Artikel lesen | |
| PANGENOMIC HEALTH | 0,120 | +1,70 % | PanGenomic Health Inc.: PanGenomic Health Announces Exclusive Distributorship Agreement with Colombian Subsidiary of Ayla Bioscience and Expiration of Non-Binding Letter of Intent | ||
| INSPIREMD | 0,605 | +7,08 % | InspireMD Inc.: InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard Prime TransCarotid Stent System | ||
| VYOME | 1,430 | -1,38 % | Vyome Holdings, Inc. GAAP EPS of -$0.13 in-line, revenue of $0.06M | ||
| IZOTROPIC | 0,064 | 0,00 % | Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement | Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - October 6, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device... ► Artikel lesen | |
| ASTRANA HEALTH | 26,400 | +0,76 % | Astrana Health, Inc. Reports Third Quarter 2026 Results | Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports record revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million, up 1,782% year-over-year... ► Artikel lesen | |
| ORGANOGENESIS | 0,730 | 0,00 % | Johnson & Johnson, GSK und Co.: Warum der Wettlauf um Zelltherapie-Plattformen gerade erst beginnt | ||
| CROSSJECT | 1,302 | -1,21 % | CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure | Cash and cash equivalents of €12.3 million as of June 30, 2026, a 2.4-fold increase compared to December 31, 2025 (€5.1 million), following the €15 million capital increase completed in May. Shareholders'... ► Artikel lesen | |
| ORIOLA | 0,770 | -1,03 % | ORIOLA OYJ: Oriola's Board of Directors resolves not to distribute an additional dividend instalment | ||
| BAUSCH+LOMB | 17,700 | -5,35 % | Bausch + Lomb Post-Surgery Eye Pain Drug Misses Study Goal But Shows Early Relief |